Skip to main content

Find Clinical Trials

Home
Conditions
Parkinson Disease

Clinical trial condition

Parkinson Disease

Explore clinical trials studying Parkinson Disease. Study availability and eligibility vary by location and protocol.

1,814 public trials 369 recruiting studies

Refine in advanced search Browse all conditions

Parkinson Disease trial results

Completed

Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

NCT00363727

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations: GSK Investigational Site Anniston, Alabama, United States

GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Phoenix, Arizona, United States

View all 69 locations

View Trial Details

Completed

Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease

NCT00823836

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: GSK Investigational Site Aichi, Japan

GSK Investigational Site Aichi, Japan

GSK Investigational Site Aichi, Japan

GSK Investigational Site Aichi, Japan

View all 54 locations

View Trial Details

Completed

Evaluation of [123I]MNI-420 and SPECT as a Marker of the Adenosine A2a Receptor in PD, HD and Healthy Subjects.

NCT00970229

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: Institute for Neurodegenerative Disorders New Haven, Connecticut, United States

View Trial Details

Completed

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions

NCT00870974

Conditions: Alzheimer Disease, Autism Spectrum Disorder, Autistic Spectrum Disorders, +33 more
Locations: Institute for Neurodegenerative Disorders New Haven, Connecticut, United States

View Trial Details

Completed

ALTROPANE® SPECT Imaging in Patients With Parkinson Disease

NCT00397228

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Molecular NeuroImaging New Haven, Connecticut, United States

View Trial Details

Completed

Study of Motor Slowing in Parkinson's Disease by a Computerized Mental Chronometry Paradigm

NCT02814201

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: CHU Amiens Amiens, France

View Trial Details

Completed

Effect of Body Suspension and Tilting Exercises in Parkinson's Disease

NCT02763891

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Serviço de Neurologia do Hospital São Lucas da PUCRS Porto Alegre, Rio Grande do Sul, Brazil

View Trial Details

Completed

Benefit From the Chin Down Maneuver in the Swallowing Performance and Self-perception of Parkinson's Disease Patients

NCT02973698

Conditions: Basal Ganglia Diseases, Behavior, Brain Diseases, +25 more
Locations: Not specified

View Trial Details

Completed

Strength Training and Different Subtypes of Parkinson´s Disease

NCT02966600

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: University School of Sports Medicine, University of Oviedo, Spain. Oviedo, Principality of Asturias, Spain

View Trial Details

Completed

Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease

NCT02267434

Conditions: Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Medical University Innsbruck, Department of Neurology Innsbruck, Austria

Studienzentrum der PROSENEX, AmbulatoriumbetriebsgesmbH an der Confraternität -Privatklinik Josefstadt Vienna, Austria

View Trial Details